PEER-REVIEWED STUDIES, EVIDENCE BASED AND REAL LIFE TESTIMONIALS FROM AN 84 YEAR OLD MAN.
The National Cancer Institute defines Cancer as
“A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord.”
This definition encapsulates the biological essence of cancer, emphasizing the uncontrolled proliferation of cells, their potential to invade local tissues, and their capacity for metastasis.
Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and multiply (through a process called cell division) to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.
Dr. Merritt suggests an alternative definition that cancer might be linked to intracellular parasites. She stated that when you look at cancer under a light microscope, it’s essentially indistinguishable from parasite egg sacs. This view leads her to propose that cancer could be treated or managed with antiparasitic drugs which has been proven to work effectively.
This is not the first time this suggestion changed the world’s view on cancer, Johannes Fibiger a Danish Physician was the first to publish on this in 1913 and later won a Nobel Prize in Physiology and Medicine in 1926 for this amazing discovery which was later debunked but now has resurfaced and it is the foundation for this groundbreaking treatment that I am about to discuss with you?
The cancer industry encompasses a vast array of entities, from pharmaceutical companies to non-governmental organizations (NGOs), radiological centers, and comprehensive treatment programs, forming a colossal economic sector. Here’s an overview of its monetary size and the underlying dynamics:
Pharmaceutical Sector:
The global market for cancer drugs alone is valued in the hundreds of billions. In 2022, it was estimated to be worth over $158 billion, with projections suggesting growth to $268 billion by 2026. This sector includes both traditional chemotherapy agents and newer, more expensive targeted therapies and immunotherapies, which can cost tens of thousands per treatment course.
Radiological Centers:
These facilities, crucial for both diagnosis and treatment, contribute significantly to the industry’s economic footprint. Investments in advanced imaging technologies like MRI and PET scans, alongside radiation therapy equipment, represent multi-billion-dollar markets. The costs associated with operating these centers, including equipment maintenance, staffing with specialized professionals, and expanding facilities, are substantial.
NGOs and Cancer Programs:
Non-profit organizations and various cancer programs play a pivotal role in education, prevention, support, and research funding. The annual budget for cancer research globally is in the billions, with entities like the National Cancer Institute (NCI) in the U.S. dispersing around $6.8 billion in fiscal year 2022. These organizations also fund patient support services, which, while not directly generating revenue, are part of the broader ecosystem that indirectly supports the industry by raising awareness and funds.
Surgery and Hospital Services:
The economic impact here includes not only the cost of surgical interventions but also the associated hospital stays, post-operative care, and follow-ups. Given that surgery remains a primary treatment for many cancers, this segment contributes significantly to healthcare spending on cancer.
Economic Incentives:
The cancer industry’s sheer size creates a scenario where there is significant financial incentive in maintaining the status quo. The development, marketing, and sale of cancer treatments are highly profitable ventures. A cure would potentially shrink this market drastically, affecting revenues for pharmaceutical companies, radiological centers, and even NGOs that rely on ongoing treatment demands for funding.
Research and Development (R&D) Dynamics:
Much of the R&D in the cancer space is focused on treatments that manage the disease rather than eradicate it entirely. This approach is partly because managing chronic conditions can be more lucrative over time than a one-time cure. Moreover, the complexity of cancer means that any potential cure would require extensive, costly research, which might not offer the same return on investment as incremental treatment advancements.
Regulatory and Patent Issues:
The path to a cure could disrupt existing patents and regulatory frameworks that protect high-profit treatments. With many cancer drugs under patent protection, a cure could lead to a loss of exclusivity, reducing profits for those who have invested heavily in current treatments.
Job and Industry Dependency:
A vast number of jobs and entire industries are built around cancer care. From oncologists to nurses, radiologists, and pharmaceutical sales representatives, many livelihoods depend on the current treatment paradigm. A cure would necessitate a significant restructuring of these job markets.
Investor and Shareholder Pressure:
Companies listed on stock exchanges are under pressure to deliver consistent growth and profits to shareholders. The uncertainty and long-term investment required for a cure might not align with the immediate financial pressures these companies face, leading to a focus on short-term gains from ongoing treatment rather than long-term solutions.
In conclusion, while the pursuit of a cancer cure is noble and necessary, the economic structures surrounding the cancer industry create complex incentives that might not always align with the rapid development of a cure. This situation underscores the need for a balanced approach that considers both economic realities and the urgent human need for effective, curative treatments.
I.E: The profit incentives tied to curing cancer is extremely low compared to the money that is made administering chemotherapy and surgery.
So even if a cure for cancer was to be found, you don’t expect to hear that from your hospital doctor because the commission on chemotherapy treatments is part of the running expenses for the hospital.
FOR YOU OR YOUR FAMILY MEMBER STRICKEN WITH CANCER IT IS PERSONAL, TO THEM IT IS JUST BUSINESS.
THIS IS WHY I HAVE CREATED THIS E-BOOK TO HELP YOU TODAY
If you have cancer.
If you have a family history of cancer.
If you have a relative or family friend who has cancer.
If you are currently being administered any form of cancer treatment (Surgery, Chemo, Radiation).
If you are currently in remission.
If you are have undergone chemo or surgery or radiation and the cancer has regrown.
If you are not any of this, you can close this page because you will find nothing of importance moving forward.
In the ever-evolving landscape of cancer research, alternative treatments have emerged as a beacon of hope for those seeking options beyond traditional therapies. These treatments often involve repurposing existing drugs or exploring natural compounds that have shown potential in laboratory and some clinical settings. This guide delves into such alternative strategies, focusing on substances like fenbendazole and ivermectin, which have piqued interest due to their antiparasitic origins and subsequent research suggesting possible anti-cancer effects.
Given the recent studies elucidating cancer’s response to antiparasitic drugs such as Fenbendazole and Ivermectin, alongside its observed characteristics reminiscent of parasitic behavior, we propose a novel conceptual framework wherein cancer can be redefined not merely as a genetic or cellular malfunction but as a complex entity exhibiting parasitic attributes. This redefinition posits cancer as a condition potentially influenced by parasitic-like mechanisms, where malignant cells adapt, proliferate, and evade host defenses in ways analogous to parasites, thus suggesting that anti-parasitic treatments might unlock new avenues in oncology by targeting these unique biological behaviors.
Conventional treatments like chemotherapy, radiation, and surgery have saved lives but has a 5% success (95% failure rate) rate, they are also very expensive and come with life altering risks, irreversible side effects that sometimes makes life much worse for patients.
Alternative treatments offer new pathways for those unresponsive to standard therapies, those who have spent money on conventional drugs with no improvements or those who can’t afford the expensive and not so reliable chemotherapy/radiation/surgery sessions. The cost of a chemo treatment in Africa ranges from $700 to $1350 in a Government owned hospital, Private Hospitals cost much more.
Why not give this a try as you will find out in this E-book that cancer can be treated with cheaper repurposed drugs that pose a much lesser risk to your life with little or no side effects.
That Cancer does not have to kill you or your family member.
That Cancer does not have to drive you to bankruptcy.
That Cancer does not have to cost your family it’s fortune.
That Due date or month when you are scheduled to die can be overturned today.
I am here to tell you that there is a way out of this misery and it won’t cost you an arm or a leg.
Chemotherapy is very expensive and even if you are rich enough to pay for it, you need to listen and go through this E-book because those drugs are not doing your body a favor.
This is not another snake oil sales man hawking herbs and supplements that don’t work. This is rare and quality information that will save your life and that of your friends and family going forward.
Here you will gain access to 100 Peer-Reviewed Studies, Expert Insights, and Case Analysis that can be summarized in 3 Major Points.
1. Credibility:
Dive into a wealth of high-quality research, including analyses from leading experts in the fields of oncology, nutrition, and molecular biology. Our content has been shaped by consultations with professionals who are at the forefront of cancer research innovation, ensuring the information is both reliable and cutting-edge.
2. Comprehensive Coverage:
Explore a holistic approach to understanding cancer through a detailed examination of metabolic pathways, stem cell behavior, and how these can be influenced by various therapeutic modalities. This report doesn’t just scratch the surface; it delves into the complexities of cancer biology, providing you with a comprehensive view that spans from cellular mechanisms to practical applications
3. Educational Intent:
This informational product is designed to educate and empower. It aims to arm you with knowledge about the latest scientific insights into cancer’s metabolic nature and potential interventions. We focus on informing about strategies that could complement conventional treatments, offering you a broader perspective on cancer management without advocating for any specific treatment plan.
In Summary, whatever information you will be getting can be argued with your Doctor and you will win that argument 100%.
The report that WE will be sharing with you is endangered and should be kept for your eyes or family members’ eyes only. It is not for anybody but it is important for everybody.
People have lost their lives because they had access to this information so please BE CAREFUL. Get your healing and move on.
A Doctor is already being prosecuted by Pharmacists and Doctors for having access to this cancer ending REMEDY and so I plead with you: BE VERY CAREFUL.
This report is here today as a result of painstaking research and ongoing litigation raised by agencies and drug companies, who would be happy to keep you uninformed and in the dark about this breakthrough. However, our desire for you to have access to good and affordable health far outweighs their concerns for profit.
Endorsed by Leading Experts in Cancer Research:
Our report has been meticulously reviewed and informed by insights from some of the most respected names in oncology and medical research, ensuring the highest standards of accuracy and relevance:
Stage 4 Patient with Bile Duct Cancer With Tumor now Cancer Free after 14 Months
Tongue Cancer Patient penned a note of Thanksgiving
70 year Old Woman with Spindle Cell
PSA drops in Stage 4 Prostate Cancer Patient from 800 to 18 in 3 months
Stage 4 Cervical Cancer Drops from 46 Points in 2 Months
Early Stage Prostate Cancer Patient’s PSA Dropped
Gastric Cancer Improves Significantly in 60 something year old man.
PSA drops in Stage 4 Prostate Cancer Patient from 1533 to 968 in 12 Days
Pancreatic Cancer CA Drops from 1349 to 450
79 Year Old Canadian Shrinks Prostate Cancer
From Stage 4 Ovarian Cancer to Cancer Free in 2 months
70 Year Old Woman Makes Dramatic Improvements From Stage 4 Breast Cancer
84 Year Old Man with Colon Cancer sees significant Improvements and is more active
Breast Cancer Patient Now Cancer Free
REMEMBER A PATIENT CURED IS ONE LESS CUSTOMER FOR THE HOSPITAL, SO WHY THEN WILL THE CURE YOU IF THEY CAN KEEP TREATING YOU FOREVER.
A SICK PERSON IS GOOD BUSINESS FOR HOSPITALS, PHARMACIES AND INSURANCE COMPANIES.
THEY PROFIT FROM YOU BEING UNHEALTHY
Not saying that hospitals and pharmacies are all bad but if we can build a rocket to travel to space then we can surely cure Cancer, Diabetes, High Blood Pressure, HIV, Tuberculosis, Alzheimer’s, Malignant Tumors, Madness ETC.
Our desire for you to be in good health without breaking the bank is why we have kept the price to this E-book at N 20,000 Naira only.
Think about it: you spend more than this on a gadget that’ll be outdated in months, but what does it really give you? A few likes on Instagram? A fleeting dopamine rush? Now imagine investing that same ₦20,000 in knowledge that could transform your health, your life, and your future.
That is why “Billion-Dollar Secret: How Repurposed Cheap Drugs Are Curing Cancer.” is very important.
This isn’t just an ebook—it’s your guide to unlocking alternative therapies, practical strategies, and life-changing insights. It’s the edge you need to make informed decisions about your health and take control of your journey.
You’re not just buying a book. You’re investing in the one thing that truly matters: YOU.
INFORMATION!!
Quality information that will change the course of your destiny.
Imagine finding out that what you need to stop cancer growth in your body can be gotten from a pharmacy and won’t cost you 1% of money needed for 1 chemo cycle?
Imagine getting access to a summary of 100 peer-reviewed studies that breakdown these simple drugs that stops the spread of cancer faster than chemotherapy with very little side effects?
Imagine that you now understand the synergy between these drugs and how they will help kill the cancer in your body?
Imagine no more because the future is here.
Let’s cut to the chase—you’re not just buying a book; you’re buying access to life-changing secrets that most people will never know. This isn’t fluff or theory—it’s a no-nonsense guide packed with insider knowledge on affordable treatments that are quietly reshaping the way we think about cancer care.
Here’s what you’ll unlock:
Breakthrough Insights into repurposed drugs like Fenbendazole and Ivermectin that are stirring excitement in the health community.
Step-by-Step Guidance on how to incorporate these alternatives safely and effectively, alongside conventional treatments.
Real-Life Testimonials from people who’ve turned these insights into actionable results in their health journey.
You’re not paying for just information—you’re paying for an advantage, a shortcut, and a chance to take control of your health journey.
What’s your health and peace of mind worth to you? For less than the cost of a flashy gadget, you’ll gain knowledge that could save you money, time, and even your life.
Q: How credible is the information in this report?
A: The information is grounded in over 100 peer-reviewed studies and has been reviewed by experts in oncology and molecular biology, including Dr. William Makis. We prioritize scientific integrity, ensuring all claims are backed by credible research.
Q: What sources did you use for this report?
A: Our sources include peer-reviewed journals, clinical studies, and expert opinions from leading researchers in cancer treatment. Notable contributors include Ilyes Baghli and Pierrick Martinez, authors of a groundbreaking protocol on cancer treatment with repurposed drugs.
Q: What is the purpose of this report?
A: Our aim is to educate and inform those interested in alternative and complementary approaches to cancer treatment. This product seeks to broaden understanding of cancer’s metabolic aspects and potential therapeutic interventions, encouraging informed discussions with healthcare providers.
Q: Is this report meant to replace conventional cancer treatments?
A: No, absolutely not. This report is a treatment guide. It can be taken along with conventional medication.
Q: Can I use the information in this report to self-treat my cancer?
A: Yes and NO. We advise that you self medicate under the guise and supervision of a healthcare practitioner.
Q: Who reviewed the content of this report?
A: The content has been reviewed by oncologists and researchers for accuracy and relevance. Dr. William Makis, among others, has contributed insights to ensure the information is scientifically sound.
Q: How current is the information in this report?
A: We strive to include the most up-to-date research available at the time of publication. However, science evolves, and we recommend checking back for updates or new editions to stay informed about the latest findings.
Disclaimer: This product is for educational purposes only and does not replace professional medical advice. Consult your healthcare provider before making any health decisions.